Frontier Investment Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
$1.01M Buy
+13,165
New +$1.01M 0.06% 102
2017
Q4
Sell
-61,307
Closed -$4.97M 238
2017
Q3
$4.97M Sell
61,307
-1,055
-2% -$80.7K 0.41% 59
2017
Q2
$4.41M Sell
62,362
-570
-0.9% -$37.9K 0.41% 60
2017
Q1
$4.27M Sell
62,932
-1,168
-2% -$82.1K 0.42% 57
2016
Q4
$4.59M Sell
64,100
-2,693
-4% -$200K 0.44% 56
2016
Q3
$52.8M Buy
66,793
+20,333
+44% +$1.65M 0.47% 51
2016
Q2
$3.88M Buy
46,460
+42,836
+1,182% +$3.8M 0.48% 60
2016
Q1
$333K Buy
+3,624
New +$327K 0.04% 133
2014
Q4
Sell
-2,100
Closed -$224K 175
2014
Q3
$224K Sell
2,100
-838
-29% -$82.1K 0.04% 148
2014
Q2
$244K Buy
+2,938
New +$229K 0.04% 144

Other funds holding GILD

Frontier Investment Management's GILD Position: Q2 2020 in Review

Frontier Investment Management opened a new position in Gilead Sciences (GILD) in Q2 2020: 13,165 shares worth $1.01M. The stake represents 0.06% of the portfolio and ranks #102 among its holdings. This is a return to the name: Frontier Investment Management previously reported a position in GILD as recently as Q3 2017.

Frontier Investment Management first reported a position in GILD in Q2 2014 and has held it in 10 quarters since. The position peaked at $52.8M in Q3 2016. 1,625 funds tracked by Wall St. Rank hold GILD as of Q2 2020.

  • Frontier Investment Management held 13,165 shares of Gilead Sciences worth $1.01M as of Q2 2020.
  • Gilead Sciences was a new Frontier Investment Management position in Q2 2020.
  • Gilead Sciences made up 0.06% of Frontier Investment Management's portfolio in Q2 2020, its #102 holding.
  • Frontier Investment Management first reported a position in Gilead Sciences in Q2 2014 and has held it in 10 quarters since.
  • Frontier Investment Management's Gilead Sciences position peaked at $52.8M in Q3 2016.
  • 1,625 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2020.

Based on Frontier Investment Management's 13F filing for Q2 2020, filed 11 Aug 2020.